Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats. 2010

Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA 92093-0804, USA.

BACKGROUND Rat strains differ in sensitivity to the disruptive effects of dopamine agonists on sensorimotor gating, measured by prepulse inhibition (PPI) of startle. For example, Sprague Dawley (SD) rats are more sensitive to PPI-disruptive effects of apomorphine (APO) compared to Long Evans (LE) rats; F1 (SDxLE) and N2 generations exhibit intermediate phenotypes. We reported that APO increased S2/S1 ratios and reduced S1 amplitudes of the N40 event-related potential (ERP) in SD rats, suggesting that it reduced sensory gating and/or sensory registration. Here, we investigated whether SD and LE rats differ in sensitivity to APO effects on N40 gating or amplitude. METHODS PPI and N40 gating were assessed contemporaneously in male SD and LE rats after APO, in a 4-day within-subject design. RESULTS Compared to SD rats, LE rats were less sensitive to the PPI-disruptive effects of APO. APO increased S2/S1 ratios paralleled by a dose-dependent reduction in S1 amplitude; SD and LE rats did not differ significantly in this measure. No clear relationship was evident between APO effects on PPI and N40 gating, nor between APO effects on startle magnitude and S1 amplitude, across strains. CONCLUSIONS SD and LE rats differ in their sensitivity to the disruptive effects of dopamine receptor activation on sensorimotor gating (PPI) but not sensory gating (N40 suppression) or sensory registration (S1 amplitude). These data suggest differences in both the neural and genetic regulation of dopamine agonist effects on these measures.

UI MeSH Term Description Entries
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D000161 Acoustic Stimulation Use of sound to elicit a response in the nervous system. Auditory Stimulation,Stimulation, Acoustic,Stimulation, Auditory
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm

Related Publications

Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
October 2011, Pharmacology, biochemistry, and behavior,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
October 1969, Laboratory animal care,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
December 2009, Psychopharmacology,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
September 2011, Psychopharmacology,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
November 1998, Pharmacology, biochemistry, and behavior,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
August 1984, Physiology & behavior,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
November 2006, Brain research,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
January 1972, Pharmacology,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
June 1990, Physiology & behavior,
Michelle R Breier, and Brittanni Lewis, and Jody M Shoemaker, and Gregory A Light, and Neal R Swerdlow
September 2003, Behavioural brain research,
Copied contents to your clipboard!